MSAFP


Also found in: Acronyms.

MSAFP

abbreviation for maternal serum alpha-fetoprotein. See maternal serum alpha-fetoprotein (MSAFP) test.

MSAFP

maternal serum alpha-fetoprotein.
References in periodicals archive ?
The coincide increase of acetylcholine-esterase and MSAFP is the marker of defeet in nervous tube.
In the middle or end of second there month of conception, measuring the amount of beta-HCG coincide with MSAFP doing for cromozomical pathies about Down syndrome.
Elevated MSAFP and low MSuE3 concentrations are highly predictive for neural tube defects.
The detection rate for NTDs is good with MSAFP alone, but only about 25 percent to 33 percent of DS pregnancies are detected if MSAFP, along with maternal age, is measured.
For predicting stillbirth, the combination of elevated MSAFP and inhibin A levels had the highest positive likelihood ratio of any of the markers individually and in combination by far (15.
Major Finding: The combination of elevated second-trimester levels of inhibin A and MSAFP had a positive likelihood ratio of 15.
Maternal weight correlates positively with blood volume and is inversely related to the MSAFP.
When used in combination, an elevated MSAFP and a low MSuE3 are highly predictive of an NTD, especially anencephaly.
The risk of Down's syndrome when the MSAFP is low, or of neural tube defect or anterior abdominal wall defect when the MS-AFP is elevated, is not immediately apparent from unmanipulated data.
Roberson said in an interview that she was aware of a large number of institutions that allow a repeat MSAFP if the initial elevation is less than 3 MoM (approximately one-third of labs in one survery), but did not know of any other studies tracking outcomes in women given a second serum screening.
was resisted until strong impetus for its adoption was provided by the medical malpractice concerns of professional organizations such as the AMA,[3] at which point MSAFP quickly became a part of standard prenatal care.
Unfortunately, only passing reference is made to what has unquestionably been the major development in mass genetic screening over the last two years; the recognition that low MSAFP levels are associated with an age-independent risk of bearing a child with Down syndrome.